IQVIA
The Global Client Partner is a senior leadership role responsible for guiding Asia-based Emerging Biopharma companies through the journey from asset development to commercialization and lifecycle growth. Acting as a trusted advisor to executive teams, the role builds strategic relationships and mobilizes IQVIA's capabilities to support critical commercial, evidence, and market access decisions. The position involves shaping commercialization strategies, accelerating launch readiness, and coordinating resources across regions to drive global business growth.
Headquarters
Durham, North Carolina, United States
Company Size
10001+ employees
Founded
2016
IQVIA is a leading global provider of data, technology, and advanced analytics focused on transforming healthcare and life sciences. The company empowers organizations to accelerate innovation, enhance patient outcomes, and expedite the market introduction of new treatments through comprehensive healthcare analytics and real-world evidence. With a commitment to Human Data Science, IQVIA combines its extensive expertise with innovative technology to improve health outcomes worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for IQVIA.
IQVIA didn’t post a salary, so this is our estimate from similar listings.
Earnest Partners LLC Decreases Stake in IQVIA Holdings Inc. $IQV
4 days ago
Asset Commercialization Partner, Emerging Biopharma
lifelancer
Asset Commercialization Partner, Emerging Biopharma
lifelancer
Asset Commercialization Partner, Emerging Biopharma
lifelancer
Director International Commercialization Immunology
Regeneron Pharmaceuticals
Asset Commercialization Partner - Emerging Biopharma
lifelancer
Director, Global Marketing, Doravirine/Islatravir Commercialization & Launch Excellence
MSD